Rare diseases
Investigational molecules
Locations
Back to the Netherlands128 clinical trials in Hague, The Netherlands across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
The NetherlandsStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
The NetherlandsStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
The NetherlandsEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
The NetherlandsIntrapleural Alteplase and Dornase Alfa versus VATS for Patients with Pleural Empyema (Parapneumonic Pleural Infection)
The NetherlandsStudy of pirtobrutinib plus epcoritamab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma
The NetherlandsRituximab and venetoclax treatment for 6 vs 26 cycles in patients with relapsed or refractory chronic lymphocytic leukemia
The NetherlandsJNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments
The NetherlandsBelzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy
The NetherlandsA study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia
The NetherlandsStudy of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma
The NetherlandsStudy of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on Acute Myeloid Leukemia (AML) and associated conditions, evaluating targeted therapies in combination with standard treatments.
Research aims to improve survival rates through personalized treatment strategies for newly diagnosed patients.
Comprehensive research on Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma, investigating novel therapeutic combinations and immunotherapy approaches.
Studies focus on improving disease-free survival rates using innovative treatment combinations.
Advanced research into targeted therapeutic approaches for hematologic malignancies, combining conventional chemotherapy with novel agents.
Trials aim to establish more effective and personalized treatment protocols for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
